Glenmark to launch Lobeglitazone in India for T2 diabetes in adults

Glenmark Pharmaceuticals Limited has become the first to launch Thiazolidinedione Lobeglitazone in India for the treatment of type 2 diabetes in adults. Marketed under the brand name LOBG, it contains lobeglitazone (0.5 mg) and is to be taken once...

Pfizer COVID vaccine clears Japan panel for use with young children

A Japanese health ministry panel recommended approving Pfizer Inc's COVID-19 vaccine for children as young as six months old....

Swedish academician, who cracked Neanderthals' DNA, wins Nobel for Medicine

Swedish geneticist Svantee Paabo, whose work provided key insights into human evolution and and how humans spread around the planet by achieving "the seemingly impossible task" of cracking the genetic code of the Neanderthals was Monday announced...

Zydus Lifesciences gets USFDA approval for generic drug

Zydus Lifesciences said it has received the USFDA's final nod to market its generic version of Mirabegron extended-release tablets used to treat overactive bladder, with 180 days of shared generic drug exclusivity. The final approval granted by...

Panel asks govt to regulate price of services such as radio therapy to make cancer care affordable

The Department-related Parliamentary Standing Committee on health and family welfare has recommended to the Central government to look at regulating the price of services such as radio therapy, under the provisions of the Essential Commodities Act...

Top five Pharma Tech trends

The new pharma health trends and the use of latest technologies such as Artificial Intelligence, Augmented Reality, additive manufacturing & Virtual Reality, are indications of a significant paradigm shift in the healthcare industry.

FDA approves Amylyx's ALS drug

Amylyx Pharmaceuticals Inc said the U.S. Food and Drug Administration approved its drug for slowing the progression of ALS, or amyotrophic lateral sclerosis, and potentially delaying death, sending shares of the company up nearly 14% in extended...

Lupin launches generic hypertension drug in US market

Drug maker Lupin said it has launched Sildenafil for Oral Suspension, indicated for the treatment of pulmonary arterial hypertension, in the US market. The firm said it has introduced the product after getting approval from the US Food...

IQVIA collaborates with Dr Reddy's lab for CRM solution

IQVIA announced that Dr Reddy’s Laboratories has selected IQVIA Orchestrated Customer Engagement (OCE) platform as its core CRM solution for its entire field force in India...

Krsnaa Diagnostics to launch 600 new diagnostics centres across India

Krsnaa Diagnostics, a leading player in the diagnostics space, announced its plans to launch 600 diagnostics centres across India...

© 2025 India Pharma Outlook. All Rights Reserved.